LY-393558

LY-393558
Identifiers
	IUPAC name 1-(2-(4-(6-fluoro-1H-indol-3-yl)-3,6-dihydropyridin-1(2H)-yl)ethyl)-3-isopropyl-6-(methylsulfonyl)-3,4-dihydro-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxide;
JSmol)	Interactive image;
	SMILES FC1=CC=C2C(NC=C2C3=CCN(CCN4S(N(C(C)C)CC5=C4C=CC(S(=O)(C)=O)=C5)(=O)=O)CC3)=C1;
	InChI InChI=1S/C26H31FN4O4S2/c1-18(2)31-17-20-14-22(36(3,32)33)5-7-26(20)30(37(31,34)35)13-12-29-10-8-19(9-11-29)24-16-28-25-15-21(27)4-6-23(24)25/h4-8,14-16,18,28H,9-13,17H2,1-3H3; Key:QUSLYAPLTMMCFE-UHFFFAOYSA-N;

LY-393558 is a

antagonist of the 5-HT_1B, 5-HT_1D, and 5-HT_2A receptors. LY-393558 was also found to reduce serotonin-induced vasoconstriction, indicating that it may have therapeutic potential for the treatment of pulmonary hypertension.^[1]^[2]

References

PMID 32333296
.

v
t
e

Retrieved from "https://en.wikipedia.org/w/index.php?title=LY-393558&oldid=1129927945"